Asthma control using a combination of mometasone furoate/formoterol: Grouped analysis of three clinical trials Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010
Paediatric asthma quality of life (PAQLQ) and their parents quality of life (PQLQ) evaluation after fluticasone propionate ( Flixotide®) treatment of asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 366s Year: 2003
Mometasone furoate/formoterol (mf/f) combination treatment in patients with moderate-to-severe asthma: findings from a 1-yr safety trial Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
A comparative trial of tiotropium, salmeterol and placebo: health-related quality of life Source: Eur Respir J 2001; 18: Suppl. 33, 26s Year: 2001
Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function Source: Eur Respir J 2012; 39: 279-289 Year: 2012
Mometasone furoate/formoterol (MF/F) combination for the treatment of asthma: safety and tolerability findings from a clinical trial in severe asthma patients Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Health-related quality of life effects of mometasone furoate dry-powder inhaler (MF DPI) in patients with mild to moderate persistent asthma previously using inhaled corticosteroids Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003
Reduction in oral corticosteroid use with mometasone furoate DPI improves health-related quality of life in patients with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 395s Year: 2002
Does health-related quality of life improve with QD and BID dosing of mometasone furoate dry-powder inhaler (MF DPI) in patients with mild to moderate persistent asthma previously using inhaled corticosteroids? Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003
Quality of life questionnaire and indirect provocation test as measure of therapeutical effects of fluticasone and salmeterol in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 287s Year: 2003
The impact of salmeterol/fluticasone propionate combination product on asthma-related quality of life Source: Eur Respir J 2001; 18: Suppl. 33, 517s Year: 2001
Indacaterol once-daily improves health-related quality of life in COPD patients: a 26-week comparison with placebo and tiotropium Source: Annual Congress 2009 - New bronchodilators Year: 2009
NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011
Indacaterol once-daily improves health-related quality of life (HRQOL) in COPD patients: a 52-week study Source: Annual Congress 2009 - New bronchodilators Year: 2009
Paediatric asthma quality of life (PAQLQ) and their parents quality of life (PQLQ) evaluation after budesonide (Pulmicort ®) / uniphyllin treatment of asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 164s Year: 2004
Health-related quality of life and asthma control in patients treated with budesonide and formoterol in a single inhaler Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001
Health related quality of life evaluation after beclomethasone dipropionate (BDP) treatment in children with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 381s Year: 2004
Montelukast versus budesonide on quality of life in asthmatics subjects Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002